Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongrun Huakang Technology Development is a China-based pharmaceutical service company that specializes in regulatory affairs, market access, and commercial distribution for imported healthcare products. The company acts as the local legal agent and applicant for overseas manufacturers navigating the National Medical Products Administration (NMPA) approval process. Its commercial portfolio includes approved imported products such as Calcium Acetate Tablets for hyperphosphatemia and Huoxue Fengshi Plaster for rheumatism and pain relief. Through these partnerships, the company helps international pharmaceutical firms establish a commercial presence in the Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhongrun Huakang Technology Development.